- Reported purity
- 99.46%99.0–99.49%
- Test date
- Jul 27, 2026
- Laboratory named
- Vanguard Laboratory
Lot details
EPI-050-MH-03
Listed prices at Mile High Compounds against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Below the market median on 12 of 37 comparable listings, above it on 20. Typical listing: 2% above market. Showing the 6 largest differences.
Product documentation
Current certificates are on file for 19 of 40 tracked peptide products from Mile High Compounds. The public index contains 36 documents. Reported test dates in this set run from Apr 10, 2026 through Jul 27, 2026. That coverage figure counts the full tracked catalogue for Mile High Compounds, including products that are currently out of stock, so it can differ from the in-stock figure above.
48% · tracked-vendor median 54%
Based on the printed test date.
Printed date is over 18 months old.
84% of current records that name a lab.
19 current records
EPI-050-MH-03
SS3-010-MH-07
SMS-050-MH-01
ADX-010-MH-01
NAD-500-MH-05
MOT-040-MH-01
CJC-005-MH-03
DSI-010-MH-04
IGF-001-MH-03
SER-010-MH-04
KPV-010-MH-04
TA1-010-MH-02
CAG-010-MH-03
ARA-012-MH-02
P28-010-MH-01
KSP-010-MH-01
SLK-010-MH-03
IPA-010-MH-02
BPC-010-MH-04
| Printed lab | Certificate | |||
|---|---|---|---|---|
| Epitalon | Vanguard Laboratory | Jul 27, 2026 | 99.46%99.0–99.49% | View COA |
| SS-31 | Vanguard Laboratory | Jul 23, 2026 | No purity printed | View COA |
| Semax | Vanguard Laboratory | Jul 15, 2026 | No purity printed | View COA |
| Adamax | Kovera Labs | Jun 16, 2026 | 99.939%99.5%+ | View COA |
| NAD+ | Kovera Labs | Jun 2, 2026 | 99.212%99.0–99.49% | View COA |
| MOTS-c | Kovera Labs | May 27, 2026 | 99.471%99.0–99.49% | View COA |
| CJC-1295 (with DAC) | Kovera Labs | May 26, 2026 | 99.652%99.5%+ | View COA |
| DSIP | KOVERA LABS | May 20, 2026 | 98.483%Under 99% | View COA |
| IGF-LR3 | Kovera Labs | May 19, 2026 | 99.874%99.5%+ | View COA |
| Sermorelin | Kovera Labs | May 19, 2026 | 99.938%99.5%+ | View COA |
| KPV | Kovera Labs | May 13, 2026 | 99.809%99.5%+ | View COA |
| Thymosin Alpha-1 | Kovera Labs | May 12, 2026 | 99.412%99.0–99.49% | View COA |
| Cagrilintide | Kovera Labs | May 9, 2026 | 99.835%99.5%+ | View COA |
| ARA-290 | KOVERA LABS | May 8, 2026 | 99.867%99.5%+ | View COA |
| PE-22-28 | Kovera Labs | May 8, 2026 | 99.868%99.5%+ | View COA |
| Kisspeptin-10 | KOVERA LABS | May 6, 2026 | 99.911%99.5%+ | View COA |
| Selank | KOVERA LABS | May 4, 2026 | 99.968%99.5%+ | View COA |
| Ipamorelin | Kovera Labs | Apr 22, 2026 | 99.978%99.5%+ | View COA |
| BPC-157 | Kovera Labs | Apr 10, 2026 | 99.857%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These numbers measure document coverage only. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.